为明确心肌病相关基因变异，研究人员对 40 例土耳其患者行临床外显子组测序（CES），发现MYBPC3变异最多。 心肌病是一种心肌细胞存在缺陷，进而导致心脏功能出现故障的病症。心肌病依据分子和（或）全身改变被分为三大类，且有多个亚型。该疾病的表现与 ...

Tenaya Therapeutics (TNYA) announced the publications of positive preclinical data for TN-201, the company’s gene therapy candidate for ...

Detailed price information for Tenaya Therapeutics Inc (TNYA-Q) from The Globe and Mail including charting and trades.

Tenaya Therapeutics reports positive preclinical data for TN-201, a gene therapy for MYBPC3-associated hypertrophic cardiomyopathy, published in Nature Communications. Tenaya Therapeutics ...

Tenaya Therapeutics, Inc. announced that it will present new data on its MYBPC3-associated hypertrophic cardiomyopathy (HCM) program at the American College of Cardiology's Annual Scientific ...